Implication of AV node blockers in patients with end-stage renal disease undergoing head and neck surgery; BRASH syndrome: a case report
Autor: | Hyunho Lee, Ju Ik Park, Jimi Oh, Hochang Kim, Moon Sik Jung |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: |
Bradycardia
medicine.medical_specialty Hyperkalemia medicine.drug_class Disease urologic and male genital diseases End stage renal disease 03 medical and health sciences End-stage renal disease 0302 clinical medicine 030202 anesthesiology Anesthesiology Internal medicine medicine In patient RD78.3-87.3 cardiovascular diseases Beta-blocker Beta blocker business.industry nutritional and metabolic diseases General Medicine female genital diseases and pregnancy complications Shock (circulatory) Cardiology Head and neck surgery cardiovascular system medicine.symptom business |
Zdroj: | Brazilian Journal of Anesthesiology, Vol 72, Iss 1, Pp 152-155 (2022) |
ISSN: | 0104-0014 |
Popis: | BRASH (Bradycardia, Renal failure, Atrioventricular [AV]-node blocker medications, Shock, and Hyperkalemia), a novel syndrome, is a synergistic interaction between AV node blockers and hyperkalemia, resulting in bradycardia. We report a case of BRASH syndrome with marked bradycardia in a patient with End-Stage Renal Disease (ESRD) associated with synergistic interaction between mild hyperkalemia and AV node blockers. Anesthesiologists should be aware of these clinical features, in which ESRD patients with baseline mild hyperkalemia are particularly susceptible to bradycardia. This report will help in its early recognition as well as enable comprehensive and appropriate treatment strategies without further invasive therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |